0001209191-23-037201.txt : 20230614 0001209191-23-037201.hdr.sgml : 20230614 20230614194846 ACCESSION NUMBER: 0001209191-23-037201 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230612 FILED AS OF DATE: 20230614 DATE AS OF CHANGE: 20230614 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Khan Amin CENTRAL INDEX KEY: 0001908376 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40655 FILM NUMBER: 231015725 MAIL ADDRESS: STREET 1: C/O GREENLIGHT BIOSCIENCES HOLDINGS, PBC STREET 2: 200 BOSTON AVENUE, SUITE 3100 CITY: MEDFORD STATE: MA ZIP: 02155 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Icosavax, Inc. CENTRAL INDEX KEY: 0001786255 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1930 BOREN AVE., SUITE 1000 CITY: SEATTLE STATE: WA ZIP: 98101 BUSINESS PHONE: (206) 737-0085 MAIL ADDRESS: STREET 1: 1930 BOREN AVE., SUITE 1000 CITY: SEATTLE STATE: WA ZIP: 98101 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-12 0 0001786255 Icosavax, Inc. ICVX 0001908376 Khan Amin C/O ICOSAVAX, INC. 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101 0 1 0 0 EVP, Head of Research & Dev. 0 Stock Option (Right to Buy) 10.16 2023-06-12 4 A 0 180000 0.00 A 2033-06-11 Common Stock 180000 180000 D 25% of the shares subject to the option will vest on June 12, 2024, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued service through the applicable vesting date. /s/ Elizabeth Bekiroglu, Attorney-in-Fact 2023-06-14